Citations

Mayo Clinic

Showing 10 of 108551 citations.

Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations
Pemmaraju, Naveen , Madanat, Yazan F. , Rizzieri, David A. , Fazal, Salman, Rampal, Raajit K. , Mannis, Gabriel N. , Wang, Eunice S. , Foran, James M. , Lane, Andrew A. , Rizzieri, David A , Rampal, Raajit K , Foran, James M , Wang, Eunice S. , Madanat, Yazan , Lane, Andrew A

Leukemia & Lymphoma | February 23, 2024 | Volume: 65 | Issue: 5 | Pages: 548-559

10.1080/10428194.2024.2305288 | PMID 38391126 Get It

Secondary Trigger Point Deactivation Surgery for Nerve Compression Headaches: A Scoping Review
Saffari, Sara , Saffari, Tiam M. , Janis, Jeffrey E.

Plastic and Reconstructive Surgery - Global Open | February 23, 2024 | Volume: 12 | Issue: 2 | Pages: e5620

10.1097/gox.0000000000005620 | PMID 38405132 Get It

Background: Primary trigger point deactivation surgery has been successful in reducing or eliminating nerve compression headaches between 79% and 90% of the time. The aim of this review article was to discuss the factors that contribute to index trigger point deactivation surgery failure, the importance of reevaluating trigger points following failure, and the options for secondary surgery. Methods: A literature search was performed using a combination of keywords involving “chronic headache” and “nerve deactivation surgery,” in databases until February 2023. Results: Data of 1071 patients were evaluated and included (11 articles). The failure rate after index trigger point deactivation surgery occurs is approximately 12%, primarily due to incomplete primary trigger point deactivation. Secondary trigger points may not appear until the primary trigger is eliminated, which occurs in 17.8% of patients. Reevaluation of previously diagnosed trigger points as well as uncovered trigger points and additional preoperative testing is indicated to help determine candidacy for further surgical deactivation. To address scarring that could contribute to failure, corticosteroid injection, acellular dermal matrix, adipofascial fat, or expanded polytetrafluoroethylene sleeves have been described with beneficial effects. For neuroma management, regenerative peripheral nerve interface, targeted muscle reinnervation, a combination of both, relocation nerve grafting, or nerve capping have also been described. Neurectomy can be performed when patients prefer anesthesia and/or paresthesia over current pain symptoms. Conclusion: Secondary trigger point deactivation surgery is indicated when there is suspicion of incomplete deactivation, internal scarring, neuroma, or newly-diagnosed trigger points.
PRIMARY SCLEROSING CHOLANGITIS IN CHILDREN:53
Zeid, I, Freese, D., Perrault, Jean, Zein, Nizar N.

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 25 | Issue: 4 | Pages: 455-455

10.1002/j.1536-4801.1997.tb01871.x Get It

ULTRASOUND GUIDED PERCUTANEOUS LIVER BIOPSY:83
Faubion, W A, Mastsumoto, J Y, Perrault, Jean, Freese, Deborah K.

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 25 | Issue: 4 | Pages: 463-463

10.1002/j.1536-4801.1997.tb01809.x Get It

LACK OF EVIDENCE FOR HEPATITIS G VIRUS AND FULMINANT HEPATIC FAILURE IN CHILDREN:55
Pérez, R., Zein, Nizar N., Freese, Deborah K., Sharp, H L, Steers, Jeffery L., Persing, David H.

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 25 | Issue: 4 | Pages: 456-456

10.1002/j.1536-4801.1997.tb01802.x Get It

APOPTOSIS EXPRESSION IN CONGENITAL HEPATIC FIBROSIS
El‐Youssef, Mounif, Mu, Yongping , Huang, L., Crawford, Susan E.

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 29 | Issue: 4 | Pages: 512-512

10.1002/j.1536-4801.1999.tb02568.x Get It

THERAPEUTIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN CHILDREN
Celli, A., Parsons, W. P., Perrault, Jean, Freese, Deborah K., Peterson, Bret, Baron, Todd H. , Gostout, Christopher J., El‐Youssef, Mounif

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 29 | Issue: 4 | Pages: 497-497

10.1002/j.1536-4801.1999.tb02523.x Get It

EXPRESSION OF TGF β1 RECEPTORS I & II IN CONGENITAL HEPATIC FIBROSIS
El‐Youssef, Mounif, Mu, Yuguang , Huang, L., Crawford, Susan E. , Mu, Y.

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 29 | Issue: 4 | Pages: 490-490

10.1002/j.1536-4801.1999.tb02502.x Get It

Predictive Value of Artificial Intelligence‐Enabled Electrocardiography in Patients With Takotsubo Cardiomyopathy
Kanaji, Yoshihisa , Ӧzcan, Ilke , Tryon, David, Ahmad, Ali , Sara, Jaskanwal Deep Singh , Lewis, B , Friedman, Paul A. , Noseworthy, Peter A. , Lerman, Lilach O. , Kakuta, Tsunekazu , Ozcan, Ilke , Tryon, David N, Lewis, Bradley R , Friedman, Paul A , Attia, Zachi I , Lerman, Amir , Noseworthy, Peter A , Kanaji, Yoshihisa , Sara, Jaskanwal D S , Attia, Zachi I. , Lerman, Amir

Journal of the American Heart Association | February 23, 2024 | Volume: 13 | Issue: 5 | Pages: No page available

10.1161/jaha.123.031859 | PMID 38390798 Get It

Background Recent studies have indicated high rates of future major adverse cardiovascular events in patients with Takotsubo cardiomyopathy (TC), but there is no well‐established tool for risk stratification. This study sought to evaluate the prognostic value of several artificial intelligence‐augmented ECG (AI‐ECG) algorithms in patients with TC. Methods and Results This study examined consecutive patients in the prospective and observational Mayo Clinic Takotsubo syndrome registry. Several previously validated AI‐ECG algorithms were used for the estimation of ECG‐ age, probability of low ejection fraction, and probability of atrial fibrillation. Multivariable models were constructed to evaluate the association of AI‐ECG and other clinical characteristics with major adverse cardiac events, defined as cardiovascular death, recurrence of TC, nonfatal myocardial infarction, hospitalization for congestive heart failure, and stroke. In the final analysis, 305 patients with TC were studied over a median follow‐up of 4.8 years. Patients with future major adverse cardiac events were more likely to be older, have a history of hypertension, congestive heart failure, worse renal function, as well as high‐risk AI‐ECG findings compared with those without. Multivariable Cox proportional hazards analysis indicated that the presence of 2 or 3 high‐risk findings detected by AI‐ECG remained a significant predictor of major adverse cardiac events in patients with TC after adjustment by conventional risk factors (hazard ratio, 4.419 [95% CI, 1.833–10.66], P =0.001). Conclusions The combined use of AI‐ECG algorithms derived from a single 12‐lead ECG might detect subtle underlying patterns associated with worse outcomes in patients with TC. This approach might be beneficial for stratifying high‐risk patients with TC.
Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion
Faridi, Kamil F. , Ong, Emily , Zimmerman, Sarah , Varosy, Paul D. , Hsu, Jonathan C. , Kusumoto, Fred , Mortazavi, Bobak J. , Minges, Karl E. , Pereira, Lucy, Lakkireddy, Dhanunjaya , Koutras, Christina, DENTON, B, Mobayed, Julie, Curtis, Jeptha P. , Ong, Emily L , Friedman, Daniel J , Hsu, Jonathan C , Kusumoto, Fred M , Mortazavi, Bobak J , Minges, Karl E , Lakkireddy, Dhanunjaya , Curtis, Jeptha P , Freeman, James V , Denton, Beth, Freeman, James V.

Circulation: Arrhythmia and Electrophysiology | February 23, 2024 | Volume: 17 | Issue: 4 | Pages: No page available

10.1161/circep.123.012424 | PMID 38390713 Get It

BACKGROUND: The National Cardiovascular Data Registry Left Atrial Appendage Occlusion Registry (LAAO) includes the vast majority of transcatheter LAAO procedures performed in the United States. The objective of this study was to develop a model predicting adverse events among patients undergoing LAAO with Watchman FLX. METHODS: Data from 41 001 LAAO procedures with Watchman FLX from July 2020 to September 2021 were used to develop and validate a model predicting in-hospital major adverse events. Randomly selected development (70%, n=28 530) and validation (30%, n=12 471) cohorts were analyzed with 1000 bootstrapped samples, using forward stepwise logistic regression to create the final model. A simplified bedside risk score was also developed using this model. RESULTS: Increased age, female sex, low preprocedure hemoglobin, no prior attempt at atrial fibrillation termination, and increased fall risk most strongly predicted in-hospital major adverse events and were included in the final model along with other clinically relevant variables. The median in-hospital risk-standardized adverse event rate was 1.50% (range, 1.03%–2.84%; interquartile range, 1.42%–1.64%). The model demonstrated moderate discrimination (development C-index, 0.67 [95% CI, 0.65–0.70] and validation C-index, 0.66 [95% CI, 0.62–0.70]) with good calibration. The simplified risk score was well calibrated with risk of in-hospital major adverse events ranging from 0.26% to 3.90% for a score of 0 to 8, respectively. CONCLUSIONS: A transcatheter LAAO risk model using National Cardiovascular Data Registry and LAAO Registry data can predict in-hospital major adverse events, demonstrated consistency across hospitals and can be used for quality improvement efforts. A simple bedside risk score was similarly predictive and may inform shared decision-making.